Advertisement
Participants can access the live conference call by dialing 800-862-9098,(US) or 785-424-1051 (International) using the conference ID: 7NBIX2. The callcan also be accessed via the webcast through the Company's website athttp://www.neurocrine.com
Advertisement
If you are unable to attend the Webcast and would like further informationon this announcement please contact the Investor Relations Department atNeurocrine Biosciences at (858) 617-7600. A replay of the Conference Call willbe available approximately one hour after the conclusion of the call bydialing 1-800-723-0520 (US) or 402-220-2653 (International) using theconference ID: 7NBIX2. The call will be archived for two weeks.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical companyfocused on neurological and endocrine diseases and disorders. The productcandidates address some of the largest pharmaceutical markets in the worldincluding insomnia, anxiety, depression, irritable bowel syndrome,endometriosis and CNS related disorders. Neurocrine Biosciences, Inc. newsreleases are available through the Company's website via the Internet athttp://www.neurocrine.com
SOURCE Neurocrine Biosciences, Inc.
